Synthetic implants have always been foreign objects the body learns to tolerate. Brinter is building 3D bioprinted tissue implants that the body absorbs, replaces, and makes its own.
Photo source:
brinter.com
When a surgeon repairs a torn rotator cuff, a
ruptured Achilles tendon, or a damaged ACL, the materials available have always
carried the same fundamental limitation. They are synthetic. The body does not
recognise them as tissue. It tolerates them, builds scar tissue around them,
and sometimes rejects them entirely. Nearly half of all rotator cuff operations
using conventional regenerative materials fail. Achilles tendon injuries take
nine to twelve months to heal, even with the best available treatments. ACL
repairs carry high re-injury rates and poor graft integration. The problem is
not the surgery. It is what the surgery puts inside the body. Brinter is
building a different answer.
Brinter's platform uses a patented 3D
bioprinter to manufacture implants from bioactive materials that mimic the
architecture of natural human tissue. The implants are bioresorbable, meaning
they do not remain in the body permanently. Instead, they degrade gradually as
the body's own healing process takes over, replacing the implant structure with
new, functional tissue. The printed architecture guides cell growth and
vascularisation, signalling the body to regenerate rather than simply scar. The
result is an implant designed not to be tolerated but to disappear, leaving
behind real tissue in its place.
What separates Brinter's approach from
conventional implant manufacturing is the depth of personalisation the platform
enables. At the design level, each implant is sized and shaped precisely to fit
the individual patient's anatomy. At the biological level, proteins, peptides,
and signalling molecules can be customised to match each patient's specific
healing profile. At the cellular level, a patient's own stem cells can be
incorporated directly into the implant before surgery, boosting regeneration,
improving integration, and reducing the risk that the body will respond to the
implant as a foreign object. Three layers of personalisation, from geometry to
biology to cells, applied to a single device printed for a single patient.
The first target application is rotator cuff
repair, where Brinter's implant is on track to become the world's first 3D
bioprinted orthopedic implant to reach commercial use. Beyond orthopedics, the
platform extends into aesthetic and reconstructive surgery. Bioprinted breast
implants guide natural tissue regeneration as an alternative to permanent
synthetic devices. Nasal implants mimic cartilage structure to support
functional facial reconstruction. Urogenital implants support improved outcomes
in reconstructive procedures that currently have very limited options.
Please subscribe to have unlimited access to our innovations.